For updates on COVID-19, please read.
Our world-class experts. Your child’s care team.
Explore Our Research
Exceptional science. Innovative cures.
Give to our mission.
Why support us?
Inspiration4 space mission
Elliott is social and loves the outdoors. He also loves St. Jude, where he's being treated for leukemia.
Read This Patient's Story
The kids of St. Jude need you to wear your mask.
We have the world's best survival rates for some of the most aggressive cancers.
Give a meaningful gift this Mother’s Day when you shop at the St. Jude Gift Shop. Your purchase will show you care and help save children’s lives.
What happens when you give the world’s brightest minds the resources to do something remarkable? Cures.
St. Jude Inspire tells the stories that inspire trust, hope and faith in the mission that drives us: Finding cures. Saving children.
St. Jude honors our past and present female faculty and staff for their incredible achievements.
Read This Article
Give sadaqah to help children battling cancer and other life-threatening diseases.
Read This Story
We share our research with the world, leading a global effort to understand, treat, and defeat pediatric cancer and other life-threatening diseases.
Help us meet our fundraising goal in celebration of the Inspiration4 space expedition.
St. Jude findings highlight genomic analysis as a tool to extend risk-directed therapy and improve outcomes for children with the most common pediatric cancer.
Results from a collaborative multi-site clinical trial show the success of adding brentuximab vedotin, reducing radiation.
Martine Roussel, Ph.D., has been elected to the 2021 Class of Fellows of the American Association for Cancer Research.
St. Jude Children’s Research Hospital are learning more about what the molecular groups of a rare pediatric brain tumor mean for clinical care.
St. Jude scientists have been selected for an international collaborative research effort to advance treatment for some leading causes of childhood cancer death.
An international research team has identified clinical factors associated with the risk of central nervous system relapse in patients with the most common childhood cancer.
More Science & Medicine